Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia

Schizophrenia Research

Volumn 55, Issue 1-2, 2002, Pages 83-88

  Landén, Mikael ^a,c   Davidsson, Pia ^a   Gottfries, Carl Gerhard ^a   Månsson, Jan Eric ^a   Blennow, Kaj ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MEDICAL RESEARCH COUNCIL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Glycerophospholipids; Gyrus cinguli; Schizophrenia; Synapse; Synaptic vesicle; Synaptophysin

Indexed keywords

GLYCEROPHOSPHOLIPID; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; BRAIN LEVEL; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; MALE; PATHOGENESIS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHIZOPHRENIA; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; FEMALE; GLYCEROPHOSPHOLIPIDS; GYRUS CINGULI; HUMANS; MALE; REFERENCE VALUES; SCHIZOPHRENIA; SYNAPTIC VESICLES; SYNAPTOPHYSIN;

EID: 0036569279     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00197-9     Document Type: Article

References (32)

1. Neurobiological investigations in cingulate cortex of schizophrenic brain
2. Alterations of neural circuitry within layer II of anterior cingulate cortex in schizophrenia
3. Synaptic degeneration in thalamus in schizophrenia
4. The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia
5. Recent advances in the neuropathology of schizophrenia
6. 2O PET study during single-trial Stroop task performance
7. Fat consumption and schizophrenia
8. Neurochemical dissection of synaptic pathology in Alzheimer's disease
9. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains
10. Defining the course of brain structural change and plasticity in schizophrenia
11. Regional brain volume change over the life-time course of schizophrenia
12. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography
13. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
14. Increased platelet phospholipase A2 activity in schizophrenia
15. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: Regional and diagnostic specificity
16. A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases
17. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging
18. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
19. Fatty acid levels in the brains of schizophrenics and normal controls
20. The membrane hypothesis of schizophrenia
21. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia
22. Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia
23. Fatty acids and schizophrenia
24. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia
25. Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid
26. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia
27. Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method
28. Abnormal reinnervation as a basis for schizophrenia: A hypothesis
29. Distribution and fatty acid composition of phosphoglycerides in normal human brain
30. A procedure for the quantitative isolation of brain gangliosides
31. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients